{
    "Trade/Device Name(s)": [
        "Methadone Assay",
        "Multidrug Calibrator Set",
        "Multidrug Controls Level 1 & 2"
    ],
    "Submitter Information": "Randox Laboratories, Ltd.",
    "510(k) Number": "K092272",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJR",
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "November 2, 2010",
    "Summary Letter Received Date": "November 4, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3620"
    ],
    "Regulation Name(s)": [
        "Methadone test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Methadone",
        "Oxazepam"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "RX analysers",
        "RX daytona",
        "RX imol"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Randox Methadone Assay, Multidrug Calibrator Set, and Multidrug Controls for qualitative and semi-quantitative detection of methadone and oxazepam using immunoassay on RX analysers",
    "Indications for Use Summary": "Intended for qualitative and semi-quantitative detection of methadone in urine, calibration and quality control of benzodiazepine and methadone assays; for prescription use only",
    "fda_folder": "Toxicology"
}